ETFsNASDAQ:QQQ
SCHD Stock Approaches Historic High With $17.7 Billion Inflows Challenging Pairing Strategy
The Schwab U.S. Dividend Equity ETF was trading close to a record high on Monday. A surge of $17.68 billion in inflows has shifted…
Market intelligence
Latest market intelligence
Fast, evidence-led coverage of the companies and events moving global markets.
All coverage
More market stories
NYSE Arca · SCHD
Dividend leadership meets record-level pricing
SCHD's 2026 rotation is backed by exceptional flows. The next decision is whether a second ETF adds genuine diversification or only a new concentration.
$35.17▲ 0.17%August 24, 2026 · 14:54 EDT
U.S. cash market open
U.S. cash market open
Gap to 52-week high−0.40%$35.31 high vs $35.17 price
YTD total return27.83%ETF Central · August 14
YTD net flows$17.68bnETF Central · August 14
30-day SEC yield3.18%Schwab · August 18
2026 total return: the value rotation is already priced in
Total return snapshots, including distributions; source dates vary from August 14–21.
YTD net flows
Demand is unusually large relative to SCHD's asset base.
SPY
$21.03bn
SCHD
$17.68bn
QQQ
$15.23bn
VYM
$4.10bn
16.2% of assets
SCHD's YTD inflows equal roughly one-sixth of its August 14 asset base. That supports liquidity and price, but raises crowding risk.
Portfolio map
Sector weights from Schwab, June 30.
Health 20.72%
Staples 20.38%
Energy 14.07%
Industrials 11.55%
Financials 10.05%
Technology 9.23%
Other 14.00%
Analyst look-through
Consensus for major holdings, not a rating on SCHD. August 24 snapshots.
| Holding | Weight | View | Target upside |
|---|---|---|---|
| Merck | 4.88% | BUY | −1.81% |
| Abbott | 4.83% | BUY | +2.51% |
| Amgen | 4.81% | BUY | −12.37% |
| Coca-Cola | 4.22% | BUY | +3.26% |
| Home Depot | 4.05% | BUY | +11.95% |
Average price targets show limited support across four of five leaders. Sources: StockAnalysis analyst pages; weights from Schwab, August 19.
Why SCHD is moving — and what the pairing changes
The signal is positive; the margin of safety is thinner.
Why it is up
Investors rotated toward dividends, cash flow and lower multiples. $17.68 billion of YTD inflows reinforced that demand.
Best complementary exposure
QQQ fills SCHD's 9.2% technology gap most directly. SPY offers broader balance with less style concentration.
Main risk
A technology rebound, higher bond yields or weaker health and energy holdings could reverse SCHD's relative lead.
Investor read
Use a second ETF to solve a documented exposure gap. Do not chase the dividend label alone: SCHD is near its high, top-ten holdings represent 41.4%, and analyst targets are mixed beneath the Buy headlines.
Sources: Schwab Asset Management, StockAnalysis, and ETF Central pages for SCHD, QQQ, SPY and VYM.
NASDAQ:WMTNYSE:CMG
Food Recalls Linked to 11,428 Illnesses as Shares of Affected Firms Outperform S&P 500
Interest in food recalls is rising as four significant U.S. outbreaks have now led to 11,428 reported illnesses. Despite this, stocks for affected retail…
Macro / policy dashboard · food safety
Food recalls: scale, channels and market pricing
Four outbreak investigations; listed companies shown only as transmission channels.
U.S. market closed
24 Aug 2026 · 17:39 EDT
24 Aug 2026 · 17:39 EDT
Reported illnesses
11,428
Across four major outbreaks
Hospitalizations
519
4.54% of reported cases
Deaths
2
Both in lettuce outbreak
Exposed-stock basket
+2.8%
vs S&P 500 −0.28% Monday
Case concentration by outbreak
Iceberg lettuce represents 95.6% of this selected four-outbreak total. Counts cover different illness-onset periods.
Investor interpretation
Current market message: recalls are being priced as contained inventory and supplier events, not broad traffic shocks.
| Exposed basket | +2.82% |
|---|---|
| S&P 500 | −0.28% |
| Relative gap | +3.10 pp |
Equal-weighted WMT, TGT, CMG and YUM closing moves. This is a market-pricing observation, not proof that recalls drove returns.
Iceberg-lettuce outbreak: reported case growth
FDA/CDC laboratory-confirmed counts. Reporting can lag illness onset by up to six weeks; the recalled lettuce should no longer be in commerce.
Outbreak comparison
| Source | Illnesses | Hosp. | Status |
|---|---|---|---|
| Lettuce / Cyclospora | 10,930 | 454 | Ongoing |
| Jalapeño / Salmonella | 431 | 57 | Ongoing |
| Sprouts / E. coli + Salmonella | 55 | 4 | Ongoing |
| Blueberries / E. coli | 12 | 4 | Recall expanded |
Listed transmission channels
| Company | Relevant channel | Aug. 24 close |
|---|---|---|
| Walmart (WMT) | Marketside lettuce; downstream products | +2.69% |
| Target (TGT) | Downstream jalapeño products | +2.69% |
| Chipotle (CMG) | Jalapeño supplier switch | +3.04% |
| Yum (YUM) | Taco Bell lettuce exposure | +2.85% |
Policy and reporting timeline
Jul. 17
Central-Mexico lettuce removed; Taco Bell supplier use stopped.
Aug. 5
Jalapeño recall widened after multistate traceback.
Aug. 19
FDA began inspection and sampling at Everything Sprouts.
Aug. 20
Lettuce cases reached 10,930; 454 hospitalizations.
Aug. 21
FDA updated jalapeño and sprout investigations.
What can change the valuation read
| Bear trigger | New shared supplier, more store lists, rising traffic weakness or litigation reserves |
|---|---|
| Watch | FDA case counts, inspection results, product distribution and same-store sales |
| Contained case | No new linked products, stable traffic and completed sanitation/supplier replacement |
Cost transmission
| Stage | Likely impact | Duration |
|---|---|---|
| Remove / refund | Inventory and logistics | Days |
| Clean / test | Labor and compliance | Days–weeks |
| Replace supplier | Procurement and margin | Weeks |
| Consumer avoidance | Traffic and mix | Potentially longer |
Data as of 24 Aug 2026, 17:39 EDT. Official outbreak counts: FDA lettuce, FDA jalapeño, FDA sprouts, CDC blueberries. Market data: WMT, TGT, CMG, YUM; S&P 500 close from AP market summary. Calculations use displayed figures and rounding.
CommoditiesStock Market
U.S. Cattle Futures Slide on Trump Beef Import Proposal, but Tight Supply Curbs Downside
U.S. cattle futures fell on Monday following President Donald Trump’s proposal for a 90-day, tariff-free import period for 300,000 metric tons of ground beef…
U.S. Beef Policy Dashboard
Trump's 90-day beef import plan
The quota looks large beside annual imports, but small beside total consumption. Futures are pricing the producer shock first.
Data through August 24, 2026
17:34 EDT / 23:34 CEST
U.S. livestock session closed
17:34 EDT / 23:34 CEST
U.S. livestock session closed
300k
metric tons, tariff-free over 90 days
10.9%
of USDA's projected 2026 beef imports
≈3%
of annual U.S. beef consumption
−1.97%
October live cattle, Aug. 24 session
One quota, three very different denominators
Investor read: The quota is meaningful for import competition and cattle prices. It is too small to produce a matching nationwide retail-price cut.
Bar lengths use separate scales to keep categories legible. Ratios: quota/imports 10.9%; quota/production 2.6%. USDA forecasts; calculated.
Monday's market verdict
| Contract | Close | Day |
|---|---|---|
| Oct live cattle | 213.62¢/lb | −1.97% |
| Sep feeder cattle | 324.15¢/lb | −1.48% |
August 24, 2026 settlements. Change calculated from August 21 closes.
Retail pressure remains hot
Year-over-year CPI, July 2026, U.S. Bureau of Labor Statistics. Ground beef averaged about $7.14/lb.
Tight herd keeps the floor firm
| Indicator | Latest | Signal |
|---|---|---|
| Beef cows | 28.5m head | −1% YoY |
| 2026 calf crop | 32.5m head | −2% YoY |
| 2026 production | 24.967bn lb | Forecast |
| 2027 availability | 59.2 lb/person | −1.3% |
USDA NASS and ERS, latest releases available August 24, 2026.
Policy path
Feb. 6
White House creates an 80,000-tonne annual quota for Argentine lean-beef trimmings.
Aug. 21
Trump announces a 300,000-tonne, 90-day tariff-free import proposal.
Aug. 24
Cattle futures fall; producer groups intensify opposition.
By Sep. 4*
Executive order expected within two weeks. Supplier countries and mechanics remain undisclosed.
*Indicative deadline based on the stated two-week window, not a confirmed date.
Who feels it first?
RanchersLower cattle bids; herd rebuilding may slow.
ProcessorsPotentially cheaper inputs; retail pass-through can narrow gains.
ConsumersSome relief, likely modest at national scale.
InflationDirectionally lower; weight in broad CPI is limited.
Sources: USDA NASS and ERS, U.S. Bureau of Labor Statistics, White House, Associated Press and August 24 livestock settlements. Policy details remain preliminary.
Stock MarketTechnology
Lucyd Shares Surge 64% After HTC Partnership, Rollout in 150 Stores
Lucyd, Inc., which continues to use the name Innovative Eyewear in corporate statements, jumped 63.77% on Monday. The smart-glasses manufacturer revealed two additional distribution…
Lucyd LUCY
Smart-eyewear momentum dashboard • COMPANY topic
U.S. after-hours active • August 24, 2026
Regular close
$1.1200
4:00:01 PM EDT
Session move
+63.77%
+$0.4361 from $0.6839
After hours
$1.1599
+3.56% at 5:09:32 PM EDT
Turnover
188.1M
42.2× three-month average
Price path — August 24
Why it moved
U.S. big-box test150+ stores
Expected retail startOctober 2026
HTC VIVE Eagle U.S. launchSeptember 2026
Disclosed deal economicsNone
The move reflects distribution optionality. Neither announcement included committed sales or minimum orders.
Volume shock
42.2× normal volume raises both liquidity and reversal risk.
Financial scale
| Metric | Latest | Context |
|---|---|---|
| Q2 revenue | $1.01M | +74% YoY |
| Gross margin | 24% | −2% prior year |
| Q2 net loss | $1.67M | 165% of revenue |
| Cash + investments | $5.20M | Aug. 11, 2026 |
| Closing market cap | $9.64M | 2.4× annualized Q2 sales |
Market-value bridge
Estimated value added: $3.75M, or 3.7× Q2 revenue. Calculation uses 8.609M shares outstanding.
Analyst coverage
Current consensusNeutral
Buy / Hold / Sell0 / 1 / 0
Maxim GroupHold
Latest actionJune 3, 2026
No active price target is listed. Thin coverage can magnify news-driven trading.
Investor checklist
September
Watch VIVE Eagle launch timing, availability and prescription conversion.
October
Track store placement, sell-through and replenishment from the unnamed retailer.
Next earnings
Look for wholesale mix, gross margin and cash use. The last quarterly loss exceeded sales.
CommoditiesEnergy
Oil Drops 2.4% as Iran Sanctions Reveal Enforcement Weakness
Oil prices dropped over $2 on Monday, even as the U.S. expanded sanctions targeting Iran. Brent ended at $92.17 per barrel, while West Texas…
CRUDE OIL · MARKET / ASSET / SECTOR
Iran sanctions landed. Oil sold the headline.
Brent and WTI ended six-session winning streaks after Washington widened pressure on Iran. The market still carries a measurable Hormuz premium.
Settled · Aug. 24, 2026
16:00 EDT / 22:00 Europe/Warsaw
16:00 EDT / 22:00 Europe/Warsaw
PRICE RESET
BrentThe rally bent. It did not break.
+5.9% Brent remains above its derived pre-streak level. *$94.39 ÷ 1.084.
FORECAST GAP
Premium versus EIA
EIA’s August outlook assumes Hormuz constraints persist through August. Its 2027 case requires inventories and production to rebuild.
CHOKEPOINT
mb/dHormuz throughput
−77%2Q26 versus 4Q25
The market is reacting to marginal barrels. That makes verified tanker flows more useful than sanction rhetoric alone.
EQUITY TRANSMISSION
Aug. 24 closeCrude proxies absorbed more damage
USO−1.80%crude futures
XOP−1.74%E&P basket
CVX−1.06%integrated major
XLE−0.83%energy sector
XOM−0.64%integrated major
46% XLE’s loss was less than half USO’s decline. Refining and chemicals can cushion integrated operators.
WHAT CHANGES THE PRICE NEXT
Three observable tests
1EnforcementEvidence that Chinese buyers or banks reduce Iran exposure.
2Physical flowConfirmed tanker passages, freight rates and insurance costs.
3U.S. inventoryEIA weekly report: Wednesday, Aug. 26, 10:30 EDT.
UPSIDE RISK Iranian retaliation restricts non-Iranian Gulf exports.DOWNSIDE RISK Traffic holds and sanctions fail to remove barrels.
BiotechnologyNASDAQ:MRNA
Moderna Shares Drop 4% as $17 Billion Valuation Gap Challenges Cancer Vaccine-Fueled Surge
Shares of Moderna, Inc. dropped 4.3% on Monday, as investors weighed the extent to which a milestone cancer-vaccine result could sustain the company's value…
Investor dashboard · NASDAQ: MRNA
Moderna’s cancer-vaccine valuation test
Science reset the probability. Full Phase 3 data must now justify the price.
Market closed
24 Aug 2026 · 16:30 EDT
24 Aug 2026 · 16:30 EDT
Close
$138.89
−4.30% Monday
Volume
31.50M
2.39× three-month average
Since Aug. 18
+120.6%
Pre-readout close: $62.96
Market value
$55.5B
Approx.; 399.24M shares
Five-session repricing
Closing priceAug. 19 volume: 199.25MAug. 24 volume: 31.50M
Valuation gap
Current price
$138.89
Consensus target
$95.67
−31.1% implied price gap. At current shares outstanding, that is about $17.3B of equity value.
Fresh analyst reset
| Firm | Rating | Target | Date |
|---|---|---|---|
| Barclays | Hold | $48 → $125 | Aug 24 |
| UBS | Hold | $50 → $150 | Aug 20 |
| Morgan Stanley | Hold | $39 → $89 | Aug 19 |
| Jefferies | Hold | $60 | Aug 19 |
| BofA | Hold | $40 → $170 | Aug 19 |
23-analyst consensus: Hold · range $25–$170
Catalyst and disclosure gap
| Trial | Phase 3 INTerpath-001; 1,137 patients |
|---|---|
| Combination | Intismeran autogene + Keytruda |
| Result | Both primary endpoints met |
| Known | RFS and DMFS statistically significant |
| Not yet disclosed | Hazard ratios, absolute curves, filing timetable |
| Next trigger | Medical-meeting presentation or regulatory guidance |
Fundamentals and runway
| Metric | 2026E | 2027E |
|---|---|---|
| Revenue | $2.11B | $2.46B |
| Growth | +8.35% | +16.66% |
| EPS | −$8.62 | −$4.58 |
Year-end 2026 cash forecast: $4.7B–$5.2B
Q2 GAAP net loss: about $0.8B. Operating-expense outlook improved by about $0.2B.
Investor decision map
| Scenario | What changes | Likely read-through |
|---|---|---|
| Bull | Large effect, clean safety, quick filing | Pipeline value broadens across tumors |
| Base | Clinically useful result, normal review | Wide target range persists |
| Bear | Modest effect or manufacturing friction | Premium over consensus compresses |
Sources and timestamps: price and volume at 24 Aug 2026, 16:30 EDT — StockAnalysis, Investing.com; analyst targets as of 24 Aug 2026 — StockAnalysis and The Fly/TipRanks; trial — company release; financials — Moderna IR. Calculations use unrounded inputs where available.
Stock Market
Tokyo Markets Braced as Earthquake Near Capital Challenges $150 Billion Tail Risk
TOKYO, August 25, 2026, 05:42 JST — Cash markets in Tokyo remained shut before Tuesday’s session, while the most recent official Osaka futures figures…
Japan earthquakes Tokyo
A contained M5.9 disruption meets a much larger Tokyo insurance tail risk.
Snapshot: 25 Aug 2026, 05:42 JST • Tokyo cash market closed; latest futures 24 Aug, 22:00 JST
JMA magnitude
5.9
23 Aug, about 02:00 JST
Reported injuries
37+
AP tally, 24 Aug
Nikkei 225
−0.74%
65,528.09 • 24 Aug close
TOPIX
+0.15%
4,073.29 • 24 Aug close
Market signal: index split, not broad flight
841 Prime shares rose658 fell51 unchanged
Interpretation: semiconductor-heavy Nikkei weakness contrasted with positive broad-market breadth. Reports pointed to chip positioning and higher yields, not earthquake liquidation.
Event facts
| Epicentre | Southern Ibaraki |
| Depth | ~70 km |
| Max intensity | Lower 5, JMA scale |
| Tsunami | None |
| Nuclear anomalies | None reported |
| Aftershock window | About one week |
Transmission channels
| Channel | Current reading | Sensitivity |
|---|---|---|
| Transport | Brief rail delays; Shinkansen normal | |
| Utilities | Local outages; one Tokyo pipe repaired | |
| Industrial supply | No broad shutdowns reported | |
| Insurance | Claims likely local; tail exposure high | |
| Financial plumbing | BoJ backup plans rehearsed |
Sensitivity bars are qualitative risk channels, not loss forecasts.
Timeline to watch
23 Aug • about 02:00 JSTM5.9 quake; rail, power and water disruptions reported.
24 Aug • 15:00 JSTNikkei −0.74%; TOPIX +0.15%; positive Prime breadth.
24 Aug • 22:00 JSTNikkei futures 65,510, just 18.09 points below cash.
Through about 30 AugJMA warning window for similar shaking remains active.
Magnitude comparison
Calculated with the standard magnitude-energy relationship: 101.5×(7.1−5.9). This is a physical comparison, not a damage estimate.
Tail-risk scale
$130–150bn
Swiss Re's insured-loss scenario for a severe Tokyo-region earthquake. It is not an estimate for the current M5.9 event.
The current market calm reflects limited observed damage. It does not remove Tokyo's concentration risk.
Tuesday decision map
| Signal | Contained case | Escalation case |
|---|---|---|
| Aftershocks | No stronger event | Similar or stronger shaking |
| Infrastructure | Services normalized | New rail, utility or data-centre outages |
| Equities | TOPIX breadth stays positive | Broad selling replaces index-only weakness |
| Credit/insurance | Local claims | Material loss disclosures or reserve changes |
Sources
AP event report
Kabutan close
OSE futures snapshot
Swiss Re scenario
BoJ continuity planning
Digital TransformationGaming
Sony Shares Climb Amid PlayStation Outage, Highlighting Digital Strategy Shift
Sony Group Corporation shares advanced on Monday, despite PlayStation users starting a week-long boycott on purchases and gameplay. The ADR finished up 1.36% at…
NYSE: SONY · COMPANY
PlayStation blackout
meets the margin machine
Sony's ADR rose as players began a seven-day boycott over the 2028 end of new physical game discs. The market is betting that stronger platform economics will outweigh a customer-trust problem.
Market status
U.S. regular session closed
Data: Aug. 24, 2026 · 4:00 p.m. EDT
U.S. regular session closed
Data: Aug. 24, 2026 · 4:00 p.m. EDT
Close
$24.25
▲ 1.36% on Aug. 24
Market cap
$142.12B
Aug. 24 close; ADR-equivalent valuation
Forward P/E
17.63×
S&P Global data, updated Aug. 24
Consensus target
$30.00
+23.7% vs. Aug. 24 close · 4 analysts
One-month price path
SONY closeBoycott begins+15.6% from Jul. 24 to Aug. 24
Daily unadjusted closes. Latest plotted point: $24.25 at the Aug. 24, 2026, 4:00 p.m. EDT close.
Street view
- 3 Strong Buy
- 1 Hold
- Target range: $23–$34
- Average: $30
52-week range$19.32–$30.34
50-day average$21.72
200-day average$22.98
RSI65.21
Aug. 24 volume3.10M
20-day average volume5.27M
G&NS sales
¥937.1B
+0.1% YoY · Q1 FY2026
Operating income
¥202.0B
+37% YoY
Operating margin
21.6%
+5.8 percentage points
June MAU
125M
+2% YoY · June record
Quarter playtime
−4%
Engagement is the pressure point
Catalyst clock
Aug. 23, 2026 · 7 p.m. localSeven-day #PSBlackout begins. Players are urged to log out and avoid spending.
Aug. 30, 2026 · 7 p.m. localCampaign ends. Store spend, subscriptions and active users become the useful evidence.
January 2028Sony plans to end physical-disc production for all newly released PlayStation games.
Bull case · economics keep winning
PlayStation's operating margin rose to 21.6% while monthly active users reached 125 million. A digital-first model can reduce physical distribution friction and deepen recurring platform spend. Sony's ADR has stayed above both key moving averages.
Bear case · trust becomes churn
Quarterly playtime already fell 4%. If the boycott turns into weaker store purchases, subscriptions or next-console demand, the margin benefit may arrive with a smaller user base. Tariff refunds and foreign exchange also boosted the latest profit gain.
What can move the stock next
1 · Engagement
Post-Aug. 30 MAU, playtime and PlayStation Plus retention.
2 · Spending
PlayStation Store sales and add-on content per active user.
3 · Hardware
Disc-console demand and the next-generation installed-base plan.
4 · Quality of profit
Separate core platform gains from FX and tariff refunds.
CommoditiesStock Market
Silver’s 77% Surge Encounters Investment Demand Scrutiny
Silver retreated on Monday following a three-day climb, while gold continued to rise. Spot silver was last trading at $68.69 an ounce at 14:25…
Silver · investor dashboard
The rally is monetary.
The demand base is mixed.
Exact subject: silver. Market data are timestamped in New York time.
MARKET / ASSET / SECTOR
Spot silver
$68.69
−0.4% · Aug 24, 14:25 EDT
COMEX front month
$68.541
−1.33% · Aug 24 settlement
One month
+18.2%
Aug 24, 08:40 EDT
One year
+77.2%
Through Aug 24 settlement
Gold / silver
67.46×
Aug 24 morning EDT
Performance by horizon
Observed moves; the weekly and monthly readings were available at 08:40 EDT on Aug. 24.
Signal: Monday's decline is small beside the longer move. The risk is positioning: investment demand is rising while industrial use is forecast lower.
2026 physical balance
Metals Focus forecast for the Silver Institute; million ounces.
| Metric | 2025 | 2026F | Δ |
|---|---|---|---|
| Total supply | 1,090.4 | 1,066.4 | −2.2% |
| Industrial | 657.4 | 639.6 | −2.7% |
| Coins / bars | 217.7 | 257.6 | +18.3% |
| Total demand | 1,130.6 | 1,112.6 | −1.6% |
| Balance | −40.3 | −46.3 | wider |
What is moving silver
Transmission channels, not price forecasts.
Weaker dollar and lower yieldsTreasury buybacks helped push the dollar lower and supported precious metals.
supportiveCoin and bar demandForecast to rise 18.3% in 2026; this is the fastest-growing demand block.
supportiveIndustrial fabricationForecast to fall 2.7%; photovoltaics and electronics are using less metal.
dragPhysical availabilityAbout 762 Moz have been drawn from stocks since 2021, increasing squeeze risk.
volatileRecyclingForecast at 211.3 Moz, up 6.9%, as high prices pull scrap into the market.
supply responseNext market checkpoints
New York dates and times where announced.
Aug 26
U.S. PCE inflation
Rates and dollar catalyst; release time to be confirmed.
Rates and dollar catalyst; release time to be confirmed.
Aug 28
Kevin Warsh at Jackson Hole
First symposium speech as Fed chair; time to be confirmed.
First symposium speech as Fed chair; time to be confirmed.
Sep 28
September COMEX contract expiry
Contract date listed Aug. 24, 06:19 UTC.
Contract date listed Aug. 24, 06:19 UTC.
Ways to take exposure
Each route carries a different risk stack.
Physical bullion
Direct metal exposure. Storage, insurance and dealer spreads reduce tracking.
iShares Silver Trust · SLV
Exchange-traded metal exposure. Fund structure, fees and market liquidity matter.
Silver miners
Operational leverage can amplify moves. Costs, grades, jurisdictions and equities add risk.
Reference zones
Observed anchors, not recommendations.
$69.47Aug. 21 COMEX weekly close.
nearby$57.66Spot silver one month earlier.
monthly base$115.08Reported 2026 high; current price remains about 40% below it.
volatility
EarningsNYSE:CRM
$12 Billion Shift in Salesforce Earnings Tied to Organic Growth as U.S. Regular Trading Closes
Shares of Salesforce Inc. gained ahead of its Wednesday results, while options suggest a significantly bigger swing following the earnings release. The stock traded…
SALESFORCE · NYSE:CRM · EARNINGS SETUP
A $12 billion earnings swing with almost no revenue cushion
Options imply a 7% move after Wednesday’s report. Consensus revenue is only $10 million above the midpoint of management’s range, leaving cRPO and underlying growth to decide the direction.
Regular session closed
Market data: August 24, 2026, 15:39 EDT / 21:39 Europe/Warsaw · Intraday quote, not official close
PRICE PATH
+$19.02Six-session recovery
The stock recovered 10.0% from August 17’s close. Monday’s verified range was $207.39–$213.17.
EVENT
Aug. 26Q2 FY2027
After market close
Webcast 17:00 EDT / 23:00 Warsaw
Webcast 17:00 EDT / 23:00 Warsaw
Options range$195.29
Spot$209.99
Upper range$224.69
The move is symmetric. It measures expected volatility, not direction.
EXPECTATIONS
Thin cushionWhat must clear the bar
| Measure | Company guide | Consensus | Read-through |
|---|---|---|---|
| Revenue | $11.27B–$11.35B | $11.32B–$11.33B | Near guide ceiling |
| Adjusted EPS | $3.25–$3.27 | $3.27–$3.28 | At/above guide ceiling |
| cRPO growth | ≈14%; 13% CC | >13% | Acceleration test |
| FY2027 revenue | $45.9B–$46.2B | Watch revision | Includes ≈3 pts Informatica |
GROWTH QUALITY
Q1 FY27Acquisition bridge
Q1 revenue was $11.133B. Removing the disclosed $444M Informatica contribution leaves $10.689B against $9.829B one year earlier.
ANALYSTS
36 ratingsPositive consensus, wide spread
Low$160
Average$238.94
High$400
Agentforce is growing fast
$1.2BAgentforce ARR
+205% year over year
+205% year over year
$3.4BAgentforce + Data 360 ARR
more than +200%
more than +200%
The earnings question is whether those products lift core growth, rather than merely improving the reported mix.
Three ways the setup can break
- cRPO growth slips below the roughly 13%–14% bar.
- Core growth remains well below reported growth.
- Interest cost offsets the $25B accelerated buyback.
Key downside marker$195.29
DECISION MAP
Numbers that change the story
Bull casecRPO at or above 14%, clean core acceleration, maintained 34.3% non-GAAP margin.
MiddleHeadline beat, but growth relies on Informatica and guidance barely moves.
Bear casecRPO below 13%, weaker organic outlook or cash-flow guide cut.
CommoditiesStock Market
Sugar Futures Fall as India Attributes Price Surge to Speculation
Sugar futures declined on Monday as the leader of India's industry assured that supplies would meet festival needs, offsetting gains sparked by the country's…
Google Trend · sugar · commodity dashboard
India opened the gate.
Sugar kept the premium.
A zero-duty import quota lifted global benchmarks, while an industry assurance triggered Monday's pullback. The next test is whether physical cargo arrives before peak festival demand.
World raw sugar
17.34¢
−1.56% · per pound
August 24, 2026 · end-of-day reference
Global futures session ended
One-month move+18.9%tight-supply premium
Duty-free quota1.0Mtraw sugar through Oct. 31
India price surge+40%roughly two months
Opening stocks3.5Mtfrom 5.0Mt last year
Benchmark climb, then reassurance
The import announcement produced a 4% policy shock. Monday's 1.56% decline reflected assurances that stocks can meet demand.
Why sugar is moving
| Force | Price channel |
|---|---|
| India buys globally | Supports New York and London futures |
| Zero duty replaces 100% | Makes imports commercially viable |
| Industry says stocks are adequate | Deflates scarcity premium |
| Festival demand starts | Keeps local balance tight |
| Brazil shipping lag | Delays physical relief until October |
India's balance sheet
| Measure | 2025/26 | Signal |
|---|---|---|
| Production | 27.9Mt | Below consumption |
| Consumption | 28.0–28.5Mt | Festival-sensitive |
| Ethanol diversion | 3.0Mt | Reduces food supply |
| Exports | 0.8Mt | Already shipped |
| Opening stocks | 3.5Mt | −30% year over year |
Policy clock
Aug. 20Quota announced; futures jump.
Aug. 21–28Import applications accepted.
Oct. 15Preferred cargo-arrival pledge.
Oct. 31Zero-duty window closes.
| Model horizon | Forecast | Vs. current |
|---|---|---|
| Quarter end | 17.77¢/lb | +2.5% |
| 12 months | 19.11¢/lb | +10.2% |
Sources: Reuters, Trading Economics, USDA Foreign Agricultural Service. Current benchmark: August 24, 2026 end-of-day reference; forecasts are model estimates, not guarantees. Mt = million metric tonnes. Commodity futures can be volatile and this dashboard is not investment advice.
EarningsNYSE:UNH
UnitedHealth Shares Up as 20x Earnings Valuation Faces Commercial Cost Risk
UnitedHealth Group Incorporated rose 2.3% to $399.06 on Monday, as technology shares dragged down the wider market and boosted the insurer's defensive profile. The…
UnitedHealth Group · NYSE: UNH
Margin repair meets an 11% commercial-cost test
Regular sessionManaged careMarket cap $361.6B
Market data: August 24, 2026, 3:37 p.m. EDT
Fundamentals: quarter ended June 30, 2026
All currency: U.S. dollars
Fundamentals: quarter ended June 30, 2026
All currency: U.S. dollars
Share price
$399.06
+2.29% vs. $390.11 prior close
2026 adjusted P/E
20.2×
Price ÷ $19.75 guidance midpoint
2027 consensus P/E
17.8×
Price ÷ $22.45 consensus EPS
Average target
$481.52
+20.7% implied upside · 30 ratings
Investor thesis
UnitedHealth is sacrificing membership to restore margins. The second-quarter medical care ratio improved 270 basis points, but commercial medical-cost growth remains modestly above 11%. The stock's forward multiple therefore prices a recovery that is real, but not yet complete.
Fresh catalyst — August 24: investor attention shifted to the commercial book, where arbitration costs and provider coding have pushed full margin recovery beyond 2027.
What moves the stock next
Watch: Q3 EPS consensus $4.09; Q3 report expected October 2026; Medicare Advantage Star Ratings expected in October.
Second-quarter scorecard
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $112.0B | $111.6B | +0.4% |
| Operating earnings | $8.0B | $5.2B | +54% |
| Medical care ratio | 86.7% | 89.4% | −270 bp |
| UnitedHealthcare margin | 4.6% | 2.4% | +220 bp |
| Optum margin | 6.2% | 4.6% | +160 bp |
| UHC membership | 48.5M | — | −525K q/q |
Guidance reset
| 2026 measure | Jan. 27 | July 16 | Signal |
|---|---|---|---|
| Adjusted EPS | >$17.75 | $19.50–$20.00 | Raised |
| Operating earnings | >$24.0B | >$25.45B | Raised |
| Cash from operations | >$18.0B | ~$24.0B | Raised |
| Share repurchases | ~$2.5B | ≥$5.0B | Doubled |
| Medical care ratio | 88.8% ±50 bp | 88.1% ±25 bp | Improved |
Recent analyst actions
| Firm | Date | Rating | Target |
|---|---|---|---|
| JPMorgan | Jul. 21 | Overweight | $516 |
| Mizuho | Jul. 21 | Outperform | $493 |
| BofA Securities | Jul. 20 | Buy | $512 |
| Wells Fargo | Jul. 2026 | Overweight | $526 |
Consensus on August 24: 19 Buy, 5 Overweight, 5 Hold, 1 Underweight, 0 Sell.
Managed-care peer tape
| Company | Price | Day | Trailing P/E |
|---|---|---|---|
| UnitedHealth | $399.06 | +2.29% | 25.6× |
| Elevance Health | $402.56 | +0.50% | 17.8× |
| CVS Health | $93.31 | +0.31% | 24.6× |
| The Cigna Group | $278.73 | +0.44% | 11.5× |
| Humana | $385.47 | +1.74% | 36.4× |
Peer quotes captured August 24, 2026, about 3:35–3:37 p.m. EDT.
Risk map
| Risk | Transmission | Dashboard trigger |
|---|---|---|
| Commercial medical costs | Claims growth outruns pricing and delays margin recovery. | Trend stays above 11% into 2027. |
| Reserve quality | Q2 MCR benefited from $860M of favorable prior-period development. | Development fades or reverses. |
| Government programs | Medicare and Medicaid rate changes pressure margins or membership. | Reimbursement trails care-cost inflation. |
| Optum execution | A slower recovery weakens the earnings bridge supporting the multiple. | Optum margin stalls below the 6.2% Q2 level. |
NASDAQ:AVGONASDAQ:MU
S&P 500 (SPX) Dips as Chip Weakness Masks Level Equal-Weight Moves
The S&P 500 fell in late afternoon trading on Monday, pressured by a drop in chip stocks despite easing Treasury yields. The benchmark index…
TechStock² • SPX INTRADAY DASHBOARD
Chip weakness masks a steadier S&P 500
The capitalization-weighted index slipped, but equal-weight exposure held flat. Semiconductors remained the main drag while financials provided the clearest offset.
U.S. REGULAR SESSION
SPY
−0.23%
$763.94 • 15:29 EDT
Equal-weight RSP
+0.03%
$221.74 • breadth proxy
Semiconductors SOXX
−2.33%
$507.92 • primary drag
Financials XLF
+1.13%
$58.13 • sector offset
Relative performance
Information gain: RSP outperformed SPY by 0.26 percentage point. Financials beat technology by 2.63 points. The index decline therefore reflects weighting and sector concentration more than a uniform selloff.
Price and range check
| Exposure | Price | Move | Low | High |
|---|---|---|---|---|
| SPY • S&P 500 | $763.94 | −0.23% | $762.12 | $765.21 |
| RSP • Equal weight | $221.74 | +0.03% | $221.25 | $222.30 |
| SOXX • Semis | $507.92 | −2.33% | $499.06 | $514.34 |
| XLK • Technology | $180.56 | −1.50% | $178.83 | $182.05 |
| XLF • Financials | $58.13 | +1.13% | $57.47 | $58.38 |
| QQQ • Nasdaq-100 | $707.73 | −0.80% | $702.76 | $710.77 |
Event map
July PCE inflationRates and valuation catalyst; released with personal income and outlays.
Nvidia fiscal Q2 resultsDirect test for AI demand, semiconductor margins and mega-cap index leadership.
Jackson Hole speechFed Chair Kevin Warsh may clarify the rate outlook and Treasury-market risks.
CommoditiesNYSE:NEM
Gold Reaches Three-Month Peak; Newmont Shares Fall as Rising Costs Limit Gains
Gold climbed to its highest level in three months on Monday, supported by a softer dollar and renewed Treasury buybacks. The gains lifted bullion…
Newmont Corporation · NYSE:NEM
Gold broke higher.
Newmont did not.
Bullion reached a three-month high, but the miner slipped as investors weighed rising mine costs, a recent share-price run and limited upside to the average analyst target.
Market snapshot
$131.04
−0.40% · −$0.52
August 24, 2026 · 14:46 EDT
U.S. regular session · USD
Gold spot$4,639.49per oz · +0.8% at 14:25 EDT
NEM day range$129.17–133.64high faded into afternoon
Market value$139.8Blargest listed gold miner
Forward signal$136.58average analyst target · +4.2%
Gold's four-session breakout
The latest move followed Treasury buyback support, a weaker dollar and the strongest gold-ETF inflow in 10 months.
Why NEM moved down
| Pressure | Evidence |
|---|---|
| Profit-taking | Shares reversed from $133.64 after a 31.5% YTD return. |
| Cost drag | Q2 by-product AISC rose 58% q/q to $1,621/oz. |
| Valuation | Average target leaves only 4.2% upside. |
| No fresh company catalyst | Monday's move was metal-led, not earnings-led. |
Operating leverage
| Measure | Value | Read-through |
|---|---|---|
| Q2 realized gold | $4,414/oz | Monday spot +$225 |
| Q2 by-product AISC | $1,621/oz | Wide margin, but costs rose |
| Q2 free cash flow | $2.2B | Record second quarter |
| 2026 production guide | 5.3Moz | Reaffirmed |
Analyst positioning
Google Finance: 11 Buy · 1 Hold · 0 Sell
| Target | Price | Vs. $131.04 |
|---|---|---|
| High | $170.00 | +29.7% |
| Average | $136.58 | +4.2% |
| Low | $110.00 | −16.1% |
Sources: Reuters gold-market report, Google Finance, Newmont Q2 2026 results, World Gold Council. Market prices are time-sensitive and carry the timestamps shown. AISC and free cash flow are company-defined non-GAAP measures. This dashboard is informational, not investment advice.
NYSE:WMTStock Market
2027 Social Security COLA Update: Oct. 14 Decision May Boost Payments by $73 Monthly
The Social Security cost-of-living adjustment for 2027 is anticipated to be announced on October 14. Projections currently suggest an increase in the range of…
Google Trend · social security 2027 cola announcement date
COLA cash support meets Walmart’s consumer slowdown
A 3.4%–3.6% preliminary benefit increase could lift retiree budgets in January. For Walmart, it is a 2027 demand cushion—not the cause of Monday’s rebound.
Market data observed August 24, 2026 at 14:30 EDT (20:30 Europe/Warsaw). U.S. regular session open. Forecast data current through August 24, 2026.
WMT price
$104.89
▲ about 1.4% vs. Friday close
2027 COLA range
3.4%–3.6%
Preliminary. Two CPI-W months remain.
AARP midpoint
+$73
Estimated monthly lift for an average retired worker.
Decision date
Oct. 14
Expected after September CPI data.
Forecasts converge—but remain provisional
July CPI-W rose 3.4% year over year. August data are due September 11.
Why WMT rose Monday
Partial reboundThe stock recovered a small part of Thursday’s roughly 9% earnings loss.
Analyst supportJefferies maintained Buy and a $120 target on August 24.
Still the overhangU.S. comparable sales grew 2.6%, the slowest pace in six years.
Important caveatNo verified source tied Monday’s WMT move to the COLA trend.
Walmart Q2 FY2027 operating pulse
Revenue reached $187.9 billion. U.S. transactions remained positive, while digital growth did more of the work.
Analyst recommendation mix
Consensus: Buy
| Firm | Rating | Target |
|---|---|---|
| Jefferies | Buy | $120 |
| Raymond James | Buy | $130 |
| Deutsche Bank | Hold | $113 |
Investor map
| Signal | What it means | Next check |
|---|---|---|
| CPI-W | The statutory COLA input; July is only one of three deciding months. | August CPI — Sept. 11 |
| Gross benefit | A 3.5% midpoint implies about $73 more monthly for an average retired worker. | Official COLA — Oct. 14 |
| Net benefit | Medicare Part B premiums can absorb part of the headline increase. | Premium notice — autumn |
| Retail read-through | Helpful for nominal budgets, but food, fuel and rent can take the cash first. | WMT Q3 — next earnings |
NASDAQ:CTSHStock Market
Visa Decision Reduces Labor Threat for Cognizant, but H-1B Cap Restricts Potential Gains
The Google search trend “judge strikes down federal immigration policy” highlights a significant shift in U.S. labor supply. On Friday, a judge in Manhattan…
Cognizant Technology Solutions · NASDAQ:CTSH
Visa ruling trims a tail risk.
It does not change the core thesis.
Market reference: Aug. 21, 2026, 16:00 EDT · Latest verified close before this report
$61.87
+1.56% session
+5.24% over five sessions
Six-session price path
Close: $58.79 → $61.87Last verified close, not live intraday data
Analyst valuation
$63.94
+3.35% implied upside
11 Strong Buy2 Buy16 Hold0 Sell
29-analyst S&P Global consensus; latest available Aug. 24, 2026.
Q2 2026 operating pulse
$5.48BRevenue · +4.5% YoY
16.0%Adjusted margin · +40 bps
$1.37Adjusted EPS · +4.6%
$29.1BTTM bookings · +5%
FY26 revenue guide$22.04B–$22.35B
FY26 adjusted EPS guide$5.70–$5.82
Buyback authorization remaining$2.3B
Workforce geography
India256,900 · 73.1%
North America41,600 · 11.8%
Other regions53,100 · 15.1%
The offshore mix dwarfs the permanent-visa channel. That keeps utilization, wages and client demand at the center of the earnings case.
What the court changed
The judge vacated a nationality-only pause affecting 75 countries. Those countries usually represent about 40%–45% of U.S. immigrant visas. Policy-only refusals return to individual review.
Permanent employment cases can benefit. Approval is not automatic.
What it did not change
H-1B and other temporary visas were outside the policy. The ruling therefore does not directly reopen Cognizant’s main temporary skilled-worker route.
An appeal or stay could also slow implementation.
Why the shares matter now
Primary driver: stronger financial-services demand, better margins and higher EPS guidance. Secondary option: a wider permanent-worker pool after the court ruling. The consensus target’s 3.3% upside suggests investors still require execution—not immigration headlines—to lift the multiple.